GIORDANI, JORDAN
 Distribuzione geografica
Continente #
NA - Nord America 2.867
AS - Asia 1.476
EU - Europa 1.270
SA - Sud America 329
Continente sconosciuto - Info sul continente non disponibili 107
AF - Africa 46
OC - Oceania 2
Totale 6.097
Nazione #
US - Stati Uniti d'America 2.746
SG - Singapore 673
IT - Italia 465
CN - Cina 294
BR - Brasile 262
DE - Germania 162
FI - Finlandia 140
HK - Hong Kong 126
VN - Vietnam 102
FR - Francia 77
GB - Regno Unito 77
IN - India 64
IE - Irlanda 62
RU - Federazione Russa 56
TR - Turchia 55
CA - Canada 54
BE - Belgio 34
SE - Svezia 33
UA - Ucraina 33
BD - Bangladesh 30
PL - Polonia 27
AR - Argentina 26
ID - Indonesia 26
NL - Olanda 20
JP - Giappone 18
MX - Messico 18
ZA - Sudafrica 18
IL - Israele 16
AT - Austria 14
EC - Ecuador 13
ES - Italia 11
IQ - Iraq 11
PK - Pakistan 11
VE - Venezuela 11
CR - Costa Rica 10
LT - Lituania 9
MK - Macedonia 9
SC - Seychelles 9
CO - Colombia 7
SA - Arabia Saudita 7
HN - Honduras 6
JM - Giamaica 6
AE - Emirati Arabi Uniti 5
MA - Marocco 5
NP - Nepal 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
EG - Egitto 4
GR - Grecia 4
JO - Giordania 4
PA - Panama 4
PE - Perù 4
PR - Porto Rico 4
PT - Portogallo 4
SV - El Salvador 4
UZ - Uzbekistan 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GP - Guadalupe 3
KE - Kenya 3
LV - Lettonia 3
NO - Norvegia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
CZ - Repubblica Ceca 2
EU - Europa 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
MY - Malesia 2
NI - Nicaragua 2
PH - Filippine 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AM - Armenia 1
AU - Australia 1
BJ - Benin 1
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MT - Malta 1
NG - Nigeria 1
Totale 5.988
Città #
Ashburn 368
Singapore 337
San Jose 272
Chandler 228
Brescia 168
New York 156
Hong Kong 124
Los Angeles 91
Council Bluffs 87
Fairfield 87
Helsinki 85
The Dalles 76
Beijing 74
Princeton 74
Munich 65
Lauterbourg 48
Wilmington 46
Milan 45
Seattle 44
Verona 43
Woodbridge 42
Turku 41
Dublin 40
Ho Chi Minh City 38
Istanbul 38
Dallas 37
Ann Arbor 34
Brussels 34
Cambridge 34
Columbus 33
Houston 33
Santa Clara 33
Shanghai 33
São Paulo 27
Chicago 26
Phoenix 25
Warsaw 25
San Francisco 24
Hanoi 22
Jakarta 22
Montreal 21
Redondo Beach 21
Buffalo 20
Atlanta 19
Moscow 19
Denver 18
Washington 18
Brooklyn 17
Chennai 16
Tokyo 16
Trento 16
Düsseldorf 15
Azzano 14
Jacksonville 14
Lappeenranta 14
Menlo Park 14
Orem 14
Boardman 13
Frankfurt am Main 12
London 12
Pune 12
Rome 12
San Diego 12
Des Moines 11
Johannesburg 10
Mumbai 9
North Bergen 9
Nuremberg 9
San José 9
Sommacampagna 9
Stockholm 9
Poplar 8
Skopje 8
Ankara 7
Boston 7
Mexico City 7
Paris 7
Philadelphia 7
Romola 7
Vienna 7
Belo Horizonte 6
Cazzago San Martino 6
Gunzenhausen 6
Kyiv 6
Portsmouth 6
Toronto 6
Amsterdam 5
Charlotte 5
Guangzhou 5
Hangzhou 5
Islington 5
Rio de Janeiro 5
Bergamo 4
Chaguanas 4
Florence 4
Gurugram 4
Kingston 4
Lima 4
Manchester 4
Miami 4
Totale 3.756
Nome #
Evaluating the Emergency Department admission and hospitalization trend for COPD Exacerbation and time-dependent Particulate Matter exposure 183
Alpha1-antitrypsin deficiency: a twenty-five years' experience. 175
Impact of Particulate Matter on Emergency Department admissions and hospitalizations for COPD Exacerbation 171
A case of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) with thrombosis of the superior mesenteric artery after ChAdOx1 nCov-19 COVID-19 Vaccine 159
Effects of short-term exposure to Particulate Matter on Emergency Department admissions for Asthma Exacerbation 156
Consequences of SARS-COV-2 Pneumonia on Lung function 153
Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy 150
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? 147
Alpha1-antitrypsin deficiency and asthma 145
RETROSPECTIVE ANALYSIS AND RESULTS OF THE ALPHA1-ANTITRYPSIN DEFICIENCY CENTER ACTIVITY IN BRESCIA 143
Ultrasonographic Evaluation of Subglottic Stenoses: A Preliminary Analysis 141
Emergency department visits for Asthma Exacerbation after short-term exposure to Particulate Matter: trend assessment in a European industrial city. 141
Phenotyping OSAH patients during wakefulness 141
Predictors of exercise-induced airways obstruction in patients with mild asthma 140
Benralizumab therapy rapidly improved the quality of life in a woman with adult-onset non-allergic eosinophilic asthma 138
Evaluating the Respiratory Function Impairments in Patients with Previous SARS-COV2 Pneumonia 136
Assessment of Small Airway Dysfunction and Z-Alpha1-Antitrypsin Polymers in Exhaled Breath Condensate in Healthy PiZZ Subjects 135
Diagnosing pneumothorax through standardized bilateral ultrasound images comparison 134
ASSESSMENT OF RESPIRATORY FUNCTION IN PATIENTS AFTER SARS-COV-2 LUNG DISEASE 132
Alpha1-antitrypsin deficiency and cardiovascular disease: questions and issues of a debated relation 129
Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool 128
Effects of short-term exposure to particulate matter on emergency department admission and hospitalization for asthma exacerbations in Brescia district 127
Role Of Particulate Matter On Emergency Department Visits For Asthma Exacerbation 126
Evaluation of a New Strategy to Predict Exercise-Induced Asthma 124
A Six-Month Follow-Up Evaluation of Lung Function in Patients with Previous SARS-COV-2 Pneumonia 124
CHARACTERIZATION OF THE AIRWAY WALL COMPLIANCE AFTER TREATMENT WITH BRONCHODILATOR IN COPD PATIENTS 124
SMALL AIRWAYS DISEASE AND Z-ALPHA1-ANTITRYPSIN POLYMERS: IS THERE A CORRELATION? 123
EVALUATION OF LUNG FUNCTION AFTER SARS-COV-2 PNEUMONIA 119
Assessment of respiratory function and exercise tolerance at 4-6 months after COVID-19 infection in patients with pneumonia of different severity 118
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up 118
Investigating the Link between Alpha-1 Antitrypsin Deficiency and Abdominal Aortic Aneurysms 118
Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients 117
Time-Dependent Relationship Between Particulate Matter Exposure and COPD Exacerbations 116
COPD EXACERBATION AND AIRBORNE POLLUTANTS: CHARACTERIZING THE ROLE OF PARTICULATE MATTER AND FINE PARTICULATE MATTER SHORT-TERM EXPOSURE 115
Simplified Daytime Approach in OSAH Phenotyping 114
Long-term alveolar-capillary diffusion impairments after severe SARS-CoV-2 pneumonia 112
PHENOTYPING PATIENTS WITH OSAH DURING WAKEFULNESS 108
CHARACTERIZATION OF THE IMPACT OF PARTICULATE MATTER AND FINE PARTICULATE MATTER ON ASTHMA EXACERBATION 108
Short-Term Exposure to Particulate Matter and Asthma: A Link Between Environment and Respiratory Emergencies 108
EXERCISE-INDUCED ASTHMA: RESEARCHING PREDICTORS IN SUBJECTS WITH MILD ASTHMA 107
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in alfa-1 anti-trypsin deficiency-related COPD development? 107
SMALL AIRWAYS DISEASE AND Z-ALPHA1-ANTITRYPSIN POLYMERS: IS THERE A CORRELATION? 106
Standardizing Bilateral Ultrasound Images Comparison for the Diagnosis of Pneumothorax: A Pilot Study 104
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study 103
Sleep-disordered breathing and pregnancy outcomes: The impact of maternal oxygen saturation 101
EXERCISE-INDUCED ASTHMA: RESEARCHING PREDICTORS IN SUBJECTS WITH MILD ASTHMA 93
Deficit Di Alfa-1 Antitripsina E Bpco: I Danni Del Ritardo Diagnostico 68
Evaluation of Long-Term Response to Biological Therapy in Severe Asthma and Considerations for Treatment Adjustment 57
24-Month assessment of respiratory function in patients hospitalized for severe SARS-CoV-2 pneumonia: a follow-up study 55
Totale 6.097
Categoria #
all - tutte 33.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.980


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022319 0 0 0 0 7 50 32 39 37 32 38 84
2022/2023599 51 77 31 47 35 115 2 110 55 0 20 56
2023/2024592 32 11 65 78 34 171 11 55 71 10 6 48
2024/20251.144 2 17 10 152 101 97 65 47 184 146 178 145
2025/20262.397 238 261 140 382 311 187 354 70 141 209 70 34
2026/2027532 68 78 129 252 5 0 0 0 0 0 0 0
Totale 6.097